| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaginosis, Bacterial | 14 | 2016 | 151 | 1.560 |
Why?
|
| Vagina | 26 | 2011 | 841 | 1.560 |
Why?
|
| Bacteroides fragilis | 42 | 2000 | 250 | 1.280 |
Why?
|
| Bacteria | 23 | 2016 | 2192 | 1.210 |
Why?
|
| Microbiological Techniques | 3 | 2016 | 97 | 1.070 |
Why?
|
| Superantigens | 4 | 2010 | 126 | 1.010 |
Why?
|
| Enterotoxins | 8 | 2013 | 366 | 0.960 |
Why?
|
| Staphylococcus aureus | 15 | 2019 | 1457 | 0.940 |
Why?
|
| Staphylococcal Infections | 15 | 2019 | 1406 | 0.930 |
Why?
|
| Bacteroides Infections | 26 | 2000 | 89 | 0.920 |
Why?
|
| Bacterial Toxins | 14 | 2013 | 925 | 0.910 |
Why?
|
| Obstetric Labor, Premature | 7 | 2010 | 272 | 0.880 |
Why?
|
| Abdominal Abscess | 10 | 2003 | 153 | 0.850 |
Why?
|
| Menstruation | 7 | 2010 | 306 | 0.800 |
Why?
|
| Pregnancy Complications, Infectious | 13 | 2015 | 2149 | 0.690 |
Why?
|
| Feces | 15 | 2019 | 1490 | 0.670 |
Why?
|
| Wound Infection | 8 | 2019 | 244 | 0.660 |
Why?
|
| Placenta | 10 | 2019 | 1709 | 0.640 |
Why?
|
| Communicable Diseases | 3 | 2016 | 871 | 0.630 |
Why?
|
| Bacteriological Techniques | 8 | 2010 | 275 | 0.590 |
Why?
|
| Microbiology | 1 | 2018 | 70 | 0.590 |
Why?
|
| Carbapenems | 4 | 2022 | 123 | 0.580 |
Why?
|
| Gastroesophageal Reflux | 2 | 2015 | 821 | 0.570 |
Why?
|
| Polysaccharides, Bacterial | 25 | 2000 | 578 | 0.550 |
Why?
|
| Clostridium | 14 | 2021 | 100 | 0.540 |
Why?
|
| Carrier State | 3 | 2010 | 522 | 0.540 |
Why?
|
| Antibodies, Bacterial | 12 | 2010 | 1464 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 29 | 2022 | 7403 | 0.520 |
Why?
|
| Microbial Interactions | 2 | 2013 | 74 | 0.510 |
Why?
|
| Bacteria, Anaerobic | 8 | 2019 | 70 | 0.490 |
Why?
|
| Saliva | 1 | 2019 | 828 | 0.480 |
Why?
|
| DNA, Bacterial | 7 | 2016 | 1471 | 0.480 |
Why?
|
| Diagnostic Tests, Routine | 4 | 2016 | 786 | 0.470 |
Why?
|
| Antacids | 1 | 2014 | 94 | 0.470 |
Why?
|
| Oropharynx | 1 | 2015 | 138 | 0.460 |
Why?
|
| Stomach | 2 | 2015 | 696 | 0.440 |
Why?
|
| Abscess | 26 | 2000 | 606 | 0.430 |
Why?
|
| Stomach Diseases | 1 | 2014 | 134 | 0.430 |
Why?
|
| Trichomonas vaginalis | 1 | 2013 | 70 | 0.420 |
Why?
|
| Bacterial Infections | 9 | 2014 | 1389 | 0.420 |
Why?
|
| Gardnerella vaginalis | 2 | 2006 | 20 | 0.410 |
Why?
|
| Lactobacillus | 9 | 2019 | 212 | 0.390 |
Why?
|
| Immunity, Innate | 4 | 2013 | 3045 | 0.380 |
Why?
|
| Urea | 2 | 2004 | 443 | 0.380 |
Why?
|
| Clindamycin | 17 | 2004 | 139 | 0.370 |
Why?
|
| Enterocolitis, Pseudomembranous | 12 | 2004 | 264 | 0.360 |
Why?
|
| Shock, Septic | 4 | 2005 | 769 | 0.360 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2013 | 697 | 0.350 |
Why?
|
| Colony Count, Microbial | 10 | 2013 | 328 | 0.350 |
Why?
|
| Nasal Cavity | 2 | 2010 | 304 | 0.350 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 533 | 0.340 |
Why?
|
| Chorioamnionitis | 4 | 2012 | 156 | 0.340 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 137 | 0.330 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2017 | 188 | 0.330 |
Why?
|
| Bacteroides | 18 | 1990 | 165 | 0.320 |
Why?
|
| Clostridium Infections | 10 | 2021 | 557 | 0.310 |
Why?
|
| Symbiosis | 3 | 2021 | 294 | 0.310 |
Why?
|
| Infant, Premature | 7 | 2014 | 2107 | 0.300 |
Why?
|
| Ureaplasma urealyticum | 1 | 2008 | 39 | 0.300 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2008 | 141 | 0.300 |
Why?
|
| Probiotics | 3 | 2007 | 378 | 0.300 |
Why?
|
| Intestines | 13 | 2014 | 1909 | 0.300 |
Why?
|
| Enterobacteriaceae | 7 | 2017 | 161 | 0.300 |
Why?
|
| Naphthyridines | 2 | 1999 | 143 | 0.300 |
Why?
|
| Prevotella | 2 | 1998 | 80 | 0.300 |
Why?
|
| Mycoplasma | 1 | 2008 | 147 | 0.290 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2018 | 238 | 0.290 |
Why?
|
| Epithelial Cells | 3 | 2013 | 3672 | 0.290 |
Why?
|
| RNA, Ribosomal, 16S | 6 | 2019 | 1033 | 0.290 |
Why?
|
| Bacteremia | 7 | 2013 | 977 | 0.290 |
Why?
|
| Enterobacter cloacae | 2 | 2019 | 22 | 0.280 |
Why?
|
| Streptococcus agalactiae | 3 | 2005 | 337 | 0.280 |
Why?
|
| Interleukin-1 | 6 | 2006 | 1248 | 0.280 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2010 | 610 | 0.280 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2010 | 730 | 0.280 |
Why?
|
| Colitis, Ulcerative | 15 | 2010 | 1921 | 0.280 |
Why?
|
| Fluoroquinolones | 2 | 1999 | 306 | 0.280 |
Why?
|
| beta-Lactamases | 3 | 2019 | 304 | 0.270 |
Why?
|
| Escherichia coli Infections | 5 | 2008 | 518 | 0.270 |
Why?
|
| beta-Lactam Resistance | 2 | 2017 | 73 | 0.260 |
Why?
|
| Pseudomonas Infections | 3 | 2019 | 621 | 0.250 |
Why?
|
| Culture Techniques | 1 | 2006 | 531 | 0.250 |
Why?
|
| Menstrual Hygiene Products | 4 | 1989 | 20 | 0.250 |
Why?
|
| Cecum | 9 | 2021 | 233 | 0.250 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 407 | 0.240 |
Why?
|
| Gels | 2 | 2003 | 420 | 0.240 |
Why?
|
| History, 20th Century | 4 | 2018 | 2764 | 0.240 |
Why?
|
| Pregnancy | 33 | 2019 | 29869 | 0.230 |
Why?
|
| Disease Models, Animal | 37 | 2016 | 18220 | 0.230 |
Why?
|
| Lung Diseases | 1 | 2014 | 1909 | 0.230 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2022 | 144 | 0.230 |
Why?
|
| Gentamicins | 10 | 2019 | 243 | 0.230 |
Why?
|
| Metronidazole | 4 | 1999 | 232 | 0.230 |
Why?
|
| Cytokines | 10 | 2011 | 7373 | 0.220 |
Why?
|
| Bacterial Adhesion | 2 | 2004 | 306 | 0.220 |
Why?
|
| Escherichia coli | 18 | 2019 | 4210 | 0.220 |
Why?
|
| Culture Media | 7 | 2010 | 895 | 0.210 |
Why?
|
| Minocycline | 3 | 2019 | 169 | 0.190 |
Why?
|
| Burns | 4 | 2019 | 1875 | 0.190 |
Why?
|
| Female | 81 | 2019 | 392203 | 0.190 |
Why?
|
| Microbial Sensitivity Tests | 11 | 2019 | 1936 | 0.190 |
Why?
|
| Klebsiella pneumoniae | 2 | 2015 | 249 | 0.180 |
Why?
|
| Bacterial Capsules | 4 | 1999 | 243 | 0.180 |
Why?
|
| Rats, Wistar | 10 | 2003 | 1848 | 0.180 |
Why?
|
| Immunization | 8 | 1995 | 1217 | 0.180 |
Why?
|
| Cervix Uteri | 2 | 2004 | 570 | 0.180 |
Why?
|
| Lung | 3 | 2015 | 9999 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2018 | 1566 | 0.180 |
Why?
|
| Publishing | 4 | 2016 | 832 | 0.170 |
Why?
|
| Blood | 6 | 2011 | 596 | 0.170 |
Why?
|
| Rats | 40 | 2003 | 23716 | 0.170 |
Why?
|
| Humans | 130 | 2022 | 760740 | 0.170 |
Why?
|
| Colitis | 6 | 2014 | 1234 | 0.170 |
Why?
|
| Carrageenan | 10 | 1988 | 71 | 0.170 |
Why?
|
| Germ-Free Life | 8 | 2021 | 186 | 0.170 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 72 | 0.160 |
Why?
|
| Peptostreptococcus | 2 | 1998 | 27 | 0.160 |
Why?
|
| Lipopolysaccharides | 6 | 2004 | 2202 | 0.160 |
Why?
|
| Tissue Adhesions | 2 | 1999 | 218 | 0.160 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2019 | 130 | 0.160 |
Why?
|
| HLA-B27 Antigen | 1 | 1998 | 63 | 0.160 |
Why?
|
| Sepsis | 6 | 2012 | 2585 | 0.160 |
Why?
|
| Amino Acids | 4 | 2021 | 1718 | 0.160 |
Why?
|
| Filtration | 1 | 2019 | 228 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 2014 | 2495 | 0.160 |
Why?
|
| Animals | 98 | 2021 | 168202 | 0.160 |
Why?
|
| Peritoneal Diseases | 4 | 1990 | 75 | 0.160 |
Why?
|
| Acetobacter | 1 | 2018 | 6 | 0.150 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1999 | 119 | 0.150 |
Why?
|
| Vancomycin | 7 | 2019 | 503 | 0.150 |
Why?
|
| Fetal Growth Retardation | 3 | 2012 | 580 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2005 | 637 | 0.150 |
Why?
|
| Anti-Infective Agents | 2 | 2011 | 983 | 0.150 |
Why?
|
| Models, Biological | 6 | 2011 | 9461 | 0.150 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 366 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 990 | 0.150 |
Why?
|
| Genes, Bacterial | 3 | 2015 | 1073 | 0.140 |
Why?
|
| Ileitis | 3 | 1994 | 39 | 0.140 |
Why?
|
| Antitoxins | 4 | 2010 | 77 | 0.140 |
Why?
|
| Methicillin Resistance | 2 | 2008 | 198 | 0.140 |
Why?
|
| T-Lymphocytes | 13 | 2012 | 10175 | 0.140 |
Why?
|
| R Factors | 1 | 2017 | 35 | 0.140 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2012 | 83 | 0.140 |
Why?
|
| Nonlinear Dynamics | 1 | 1999 | 491 | 0.140 |
Why?
|
| Guinea Pigs | 12 | 2004 | 1310 | 0.130 |
Why?
|
| Virulence | 10 | 2021 | 1299 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2010 | 4340 | 0.130 |
Why?
|
| Proctocolectomy, Restorative | 3 | 1994 | 190 | 0.130 |
Why?
|
| Microcephaly | 2 | 2010 | 425 | 0.130 |
Why?
|
| Gestational Age | 7 | 2015 | 3577 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2018 | 745 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2000 | 1148 | 0.130 |
Why?
|
| Ammonia | 1 | 1997 | 237 | 0.130 |
Why?
|
| Clotrimazole | 1 | 1995 | 76 | 0.130 |
Why?
|
| Automation, Laboratory | 1 | 2016 | 102 | 0.130 |
Why?
|
| Ecosystem | 3 | 2012 | 487 | 0.130 |
Why?
|
| Female Urogenital Diseases | 1 | 2015 | 57 | 0.120 |
Why?
|
| Anal Canal | 2 | 2010 | 374 | 0.120 |
Why?
|
| Developmental Disabilities | 2 | 2015 | 1509 | 0.120 |
Why?
|
| Metagenome | 3 | 2014 | 448 | 0.120 |
Why?
|
| Intestinal Mucosa | 9 | 2014 | 3031 | 0.120 |
Why?
|
| Pneumonia, Bacterial | 1 | 2018 | 315 | 0.120 |
Why?
|
| Premature Birth | 5 | 2011 | 1782 | 0.120 |
Why?
|
| Borrelia burgdorferi Group | 2 | 1991 | 97 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 1703 | 0.120 |
Why?
|
| Lyme Disease | 2 | 1991 | 631 | 0.120 |
Why?
|
| Intelligence | 1 | 2019 | 923 | 0.120 |
Why?
|
| Streptococcal Infections | 4 | 2005 | 617 | 0.120 |
Why?
|
| Pregnancy Outcome | 4 | 2011 | 2921 | 0.120 |
Why?
|
| Citrobacter rodentium | 1 | 2014 | 65 | 0.110 |
Why?
|
| Phagocytes | 1 | 1996 | 295 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2015 | 755 | 0.110 |
Why?
|
| Cellulose | 2 | 2011 | 117 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2005 | 262 | 0.110 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2013 | 23 | 0.110 |
Why?
|
| Esophageal pH Monitoring | 1 | 2015 | 203 | 0.110 |
Why?
|
| Cytotoxins | 6 | 1997 | 153 | 0.110 |
Why?
|
| Interleukin-10 | 4 | 2004 | 1171 | 0.110 |
Why?
|
| Biguanides | 1 | 2013 | 21 | 0.110 |
Why?
|
| Male | 72 | 2019 | 360402 | 0.110 |
Why?
|
| Peritonitis | 5 | 1995 | 368 | 0.110 |
Why?
|
| CpG Islands | 1 | 2017 | 1192 | 0.110 |
Why?
|
| Enterococcus | 2 | 2008 | 159 | 0.110 |
Why?
|
| Candidiasis | 1 | 1995 | 365 | 0.110 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 754 | 0.110 |
Why?
|
| Wound Healing | 4 | 2019 | 2802 | 0.100 |
Why?
|
| Genetic Variation | 3 | 2017 | 6561 | 0.100 |
Why?
|
| Bacillaceae Infections | 1 | 2012 | 8 | 0.100 |
Why?
|
| Inflammation | 5 | 2017 | 10759 | 0.100 |
Why?
|
| Swine | 8 | 2019 | 5908 | 0.100 |
Why?
|
| Bacteria, Aerobic | 3 | 2008 | 24 | 0.100 |
Why?
|
| Security Measures | 2 | 2003 | 82 | 0.100 |
Why?
|
| Acetates | 4 | 1992 | 321 | 0.100 |
Why?
|
| Bacillus cereus | 1 | 2012 | 36 | 0.100 |
Why?
|
| Placenta Diseases | 3 | 2012 | 199 | 0.100 |
Why?
|
| Povidone-Iodine | 1 | 1992 | 55 | 0.100 |
Why?
|
| Bioterrorism | 2 | 2003 | 144 | 0.100 |
Why?
|
| Glucans | 1 | 1992 | 68 | 0.100 |
Why?
|
| Cricetinae | 11 | 2004 | 2424 | 0.100 |
Why?
|
| Quality Control | 1 | 2015 | 831 | 0.100 |
Why?
|
| Infant, Newborn | 15 | 2014 | 26183 | 0.100 |
Why?
|
| Carboxymethylcellulose Sodium | 2 | 2003 | 38 | 0.100 |
Why?
|
| Adult | 31 | 2019 | 220995 | 0.100 |
Why?
|
| Immunity | 1 | 2017 | 994 | 0.100 |
Why?
|
| Horse Diseases | 2 | 1989 | 55 | 0.100 |
Why?
|
| Dog Diseases | 2 | 1990 | 141 | 0.100 |
Why?
|
| Diabetes Complications | 2 | 2009 | 1315 | 0.100 |
Why?
|
| Mesocricetus | 7 | 2004 | 252 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2012 | 335 | 0.090 |
Why?
|
| Dogs | 3 | 1991 | 3837 | 0.090 |
Why?
|
| Oxygen | 3 | 2000 | 4226 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 1049 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 1999 | 1683 | 0.090 |
Why?
|
| beta-Glucans | 1 | 1992 | 123 | 0.090 |
Why?
|
| Deoxycholic Acid | 1 | 2011 | 53 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2007 | 397 | 0.090 |
Why?
|
| Puerperal Infection | 1 | 2011 | 44 | 0.090 |
Why?
|
| Actinomycetales | 1 | 2011 | 33 | 0.090 |
Why?
|
| Actinomycetales Infections | 1 | 2011 | 30 | 0.090 |
Why?
|
| Editorial Policies | 1 | 2016 | 458 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2010 | 578 | 0.090 |
Why?
|
| Proteus mirabilis | 1 | 2010 | 24 | 0.090 |
Why?
|
| Immunity, Cellular | 6 | 1990 | 1550 | 0.090 |
Why?
|
| Pleurisy | 1 | 2011 | 54 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1391 | 0.090 |
Why?
|
| Carbohydrates | 2 | 1992 | 390 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6074 | 0.090 |
Why?
|
| Francisella tularensis | 1 | 2011 | 60 | 0.090 |
Why?
|
| Salmonella enterica | 1 | 2010 | 76 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 1995 | 753 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2015 | 751 | 0.090 |
Why?
|
| Urine | 1 | 2012 | 362 | 0.090 |
Why?
|
| Antigens, CD1d | 2 | 2009 | 228 | 0.090 |
Why?
|
| Albumins | 1 | 2013 | 575 | 0.090 |
Why?
|
| Ceftizoxime | 1 | 1990 | 5 | 0.090 |
Why?
|
| Antigens, Bacterial | 13 | 2004 | 1141 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2010 | 14649 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2010 | 96 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 933 | 0.090 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 3 | 1979 | 15 | 0.090 |
Why?
|
| Adolescent | 10 | 2019 | 88247 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 2 | 2014 | 710 | 0.080 |
Why?
|
| Administration, Topical | 3 | 2016 | 703 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2019 | 1272 | 0.080 |
Why?
|
| Borrelia Infections | 1 | 1989 | 17 | 0.080 |
Why?
|
| Child Behavior Disorders | 1 | 2014 | 804 | 0.080 |
Why?
|
| Peritoneal Cavity | 1 | 1989 | 135 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 1998 | 1529 | 0.080 |
Why?
|
| Laryngoscopy | 1 | 2015 | 707 | 0.080 |
Why?
|
| Abdomen | 10 | 1994 | 1128 | 0.080 |
Why?
|
| Immunologic Tests | 1 | 1990 | 104 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2012 | 483 | 0.080 |
Why?
|
| Chemokines | 1 | 2013 | 954 | 0.080 |
Why?
|
| beta-Defensins | 1 | 2009 | 59 | 0.080 |
Why?
|
| Bronchoscopy | 1 | 2015 | 909 | 0.080 |
Why?
|
| Anesthesia, Epidural | 1 | 2011 | 232 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 1997 | 1624 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4242 | 0.080 |
Why?
|
| Housekeeping, Hospital | 1 | 2008 | 17 | 0.080 |
Why?
|
| Prenatal Diagnosis | 2 | 2014 | 1265 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2018 | 1310 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 875 | 0.080 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2009 | 78 | 0.080 |
Why?
|
| Patients' Rooms | 1 | 2008 | 62 | 0.080 |
Why?
|
| Infant | 9 | 2015 | 36157 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3798 | 0.080 |
Why?
|
| Hyaluronic Acid | 2 | 2003 | 483 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2013 | 18937 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2012 | 702 | 0.070 |
Why?
|
| Vancomycin Resistance | 1 | 2008 | 125 | 0.070 |
Why?
|
| Interleukin-8 | 2 | 2004 | 696 | 0.070 |
Why?
|
| Mice | 28 | 2021 | 81368 | 0.070 |
Why?
|
| Milk | 1 | 2010 | 442 | 0.070 |
Why?
|
| Head | 2 | 2010 | 922 | 0.070 |
Why?
|
| Child, Preschool | 8 | 2015 | 42193 | 0.070 |
Why?
|
| Time Factors | 9 | 2012 | 39908 | 0.070 |
Why?
|
| Enterobacter | 3 | 2014 | 44 | 0.070 |
Why?
|
| Plasmids | 4 | 2022 | 2265 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 1748 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 687 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 2006 | 315 | 0.070 |
Why?
|
| Bacterial Proteins | 4 | 2017 | 3842 | 0.070 |
Why?
|
| Macrophages | 4 | 2011 | 5758 | 0.070 |
Why?
|
| Carbohydrate Sequence | 6 | 2000 | 411 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2022 | 54364 | 0.070 |
Why?
|
| Fermentation | 2 | 2021 | 142 | 0.070 |
Why?
|
| Ascitic Fluid | 4 | 2008 | 189 | 0.070 |
Why?
|
| Child | 8 | 2019 | 80089 | 0.070 |
Why?
|
| Nose | 1 | 2010 | 521 | 0.070 |
Why?
|
| Retinopathy of Prematurity | 1 | 2011 | 439 | 0.070 |
Why?
|
| Immunization, Passive | 7 | 1994 | 616 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2008 | 615 | 0.070 |
Why?
|
| Erythromycin | 2 | 2004 | 115 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2012 | 2948 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2006 | 2135 | 0.070 |
Why?
|
| Tetracycline | 2 | 1978 | 216 | 0.070 |
Why?
|
| Periodicals as Topic | 2 | 2016 | 1463 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 1998 | 2423 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2019 | 8619 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 2 | 2014 | 1454 | 0.060 |
Why?
|
| Interleukins | 1 | 2010 | 783 | 0.060 |
Why?
|
| Infant Food | 2 | 1983 | 139 | 0.060 |
Why?
|
| Serotyping | 2 | 2004 | 325 | 0.060 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 474 | 0.060 |
Why?
|
| Species Specificity | 7 | 2012 | 2410 | 0.060 |
Why?
|
| Anaerobiosis | 8 | 2010 | 139 | 0.060 |
Why?
|
| Vaginal Smears | 2 | 2006 | 499 | 0.060 |
Why?
|
| Water | 1 | 2011 | 1409 | 0.060 |
Why?
|
| Exudates and Transudates | 2 | 2003 | 174 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 166 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2690 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2004 | 851 | 0.060 |
Why?
|
| Probability | 3 | 2005 | 2475 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1725 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22153 | 0.060 |
Why?
|
| Boston | 6 | 2019 | 9313 | 0.060 |
Why?
|
| Phagocytosis | 1 | 1989 | 1526 | 0.060 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 2088 | 0.050 |
Why?
|
| Logistic Models | 6 | 2014 | 13248 | 0.050 |
Why?
|
| Butyrates | 3 | 2021 | 169 | 0.050 |
Why?
|
| Cohort Studies | 10 | 2012 | 41464 | 0.050 |
Why?
|
| Computers | 2 | 1999 | 591 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2017 | 4392 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 795 | 0.050 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 17630 | 0.050 |
Why?
|
| Fever | 1 | 2011 | 1618 | 0.050 |
Why?
|
| Prevalence | 3 | 2010 | 15702 | 0.050 |
Why?
|
| Salicylates | 1 | 1983 | 127 | 0.050 |
Why?
|
| Risk Factors | 12 | 2014 | 74128 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 3 | 2006 | 1202 | 0.050 |
Why?
|
| Middle Aged | 13 | 2019 | 220603 | 0.050 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 5463 | 0.050 |
Why?
|
| Cell Line | 3 | 2011 | 15577 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 4 | 1998 | 825 | 0.050 |
Why?
|
| Cesarean Section | 2 | 2008 | 1396 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39062 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2016 | 1376 | 0.050 |
Why?
|
| RNA | 1 | 2012 | 2713 | 0.050 |
Why?
|
| Colestipol | 2 | 1978 | 11 | 0.050 |
Why?
|
| Clostridium perfringens | 2 | 1979 | 29 | 0.050 |
Why?
|
| Young Adult | 4 | 2019 | 59191 | 0.050 |
Why?
|
| Information Services | 1 | 2003 | 236 | 0.050 |
Why?
|
| Streptococcus pyogenes | 1 | 2004 | 292 | 0.050 |
Why?
|
| Cell Degranulation | 3 | 2009 | 277 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 998 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 238 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2004 | 404 | 0.050 |
Why?
|
| Polyamines | 2 | 1978 | 133 | 0.050 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 783 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 12 | 2012 | 22117 | 0.040 |
Why?
|
| Science | 1 | 2003 | 239 | 0.040 |
Why?
|
| Terrorism | 1 | 2003 | 210 | 0.040 |
Why?
|
| Phylogeny | 3 | 2014 | 2805 | 0.040 |
Why?
|
| Automation | 2 | 2012 | 585 | 0.040 |
Why?
|
| Access to Information | 1 | 2003 | 316 | 0.040 |
Why?
|
| Unnecessary Procedures | 2 | 2003 | 414 | 0.040 |
Why?
|
| Age Distribution | 1 | 2005 | 2872 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2002 | 439 | 0.040 |
Why?
|
| Sudden Infant Death | 1 | 1982 | 292 | 0.040 |
Why?
|
| Child Language | 1 | 2019 | 62 | 0.040 |
Why?
|
| Keratinocytes | 2 | 2016 | 790 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2013 | 3743 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3708 | 0.040 |
Why?
|
| Antibiosis | 1 | 1999 | 45 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2019 | 100 | 0.040 |
Why?
|
| Fusobacterium | 7 | 1979 | 53 | 0.040 |
Why?
|
| Conjugation, Genetic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 15908 | 0.040 |
Why?
|
| Rodent Diseases | 1 | 1978 | 53 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 117 | 0.040 |
Why?
|
| Staphylococcus | 4 | 1994 | 153 | 0.040 |
Why?
|
| Therapeutic Irrigation | 2 | 2006 | 289 | 0.040 |
Why?
|
| Bacillus | 2 | 1994 | 78 | 0.040 |
Why?
|
| Leukocyte Count | 4 | 1992 | 1597 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 2802 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2851 | 0.040 |
Why?
|
| Alginates | 1 | 2019 | 248 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2021 | 1131 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3394 | 0.040 |
Why?
|
| Spleen | 2 | 2003 | 2286 | 0.040 |
Why?
|
| Peritoneum | 2 | 1982 | 225 | 0.040 |
Why?
|
| Biological Availability | 1 | 1998 | 389 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2019 | 9644 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2053 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 933 | 0.040 |
Why?
|
| Systems Biology | 1 | 2021 | 481 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3979 | 0.040 |
Why?
|
| Streptococcus | 5 | 1994 | 197 | 0.040 |
Why?
|
| Microscopy, Electron | 6 | 1993 | 2561 | 0.040 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 967 | 0.040 |
Why?
|
| Research | 2 | 2003 | 1977 | 0.040 |
Why?
|
| Hospital Information Systems | 1 | 2000 | 394 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 522 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3205 | 0.040 |
Why?
|
| Corynebacterium | 4 | 1994 | 48 | 0.040 |
Why?
|
| Enterococcus faecium | 1 | 1998 | 101 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2003 | 802 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2012 | 4483 | 0.040 |
Why?
|
| Data Display | 1 | 1997 | 175 | 0.040 |
Why?
|
| Transformation, Bacterial | 1 | 2017 | 76 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3688 | 0.030 |
Why?
|
| Risk Assessment | 6 | 2012 | 23974 | 0.030 |
Why?
|
| Horses | 2 | 1989 | 300 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1978 | 385 | 0.030 |
Why?
|
| Intestine, Small | 2 | 2009 | 1207 | 0.030 |
Why?
|
| Methylene Blue | 1 | 1997 | 155 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12043 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10754 | 0.030 |
Why?
|
| Fungi | 2 | 2012 | 338 | 0.030 |
Why?
|
| Cross Reactions | 2 | 1995 | 816 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 1999 | 529 | 0.030 |
Why?
|
| Women's Health | 1 | 2006 | 2066 | 0.030 |
Why?
|
| Protein Deficiency | 1 | 1996 | 59 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1999 | 6339 | 0.030 |
Why?
|
| Polymers | 1 | 1983 | 1614 | 0.030 |
Why?
|
| Aerobiosis | 3 | 2010 | 100 | 0.030 |
Why?
|
| Random Allocation | 2 | 2016 | 2392 | 0.030 |
Why?
|
| Colon | 3 | 2010 | 1791 | 0.030 |
Why?
|
| Cecal Diseases | 3 | 1981 | 49 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 350 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2019 | 272 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4739 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 730 | 0.030 |
Why?
|
| Invertebrate Hormones | 1 | 1995 | 24 | 0.030 |
Why?
|
| Prevotella melaninogenica | 3 | 1979 | 13 | 0.030 |
Why?
|
| Proteus vulgaris | 1 | 2014 | 8 | 0.030 |
Why?
|
| Biological Assay | 1 | 1997 | 626 | 0.030 |
Why?
|
| Mast Cells | 2 | 1992 | 1392 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 1979 | 503 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 720 | 0.030 |
Why?
|
| Breast Feeding | 3 | 2012 | 1355 | 0.030 |
Why?
|
| Specimen Handling | 2 | 1997 | 701 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2006 | 299 | 0.030 |
Why?
|
| Cross Infection | 2 | 2017 | 1422 | 0.030 |
Why?
|
| Molecular Structure | 2 | 1995 | 1878 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 151 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2008 | 412 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 1998 | 1557 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1999 | 1139 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 26065 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 493 | 0.030 |
Why?
|
| Clone Cells | 1 | 2017 | 1657 | 0.030 |
Why?
|
| False Positive Reactions | 2 | 2000 | 957 | 0.030 |
Why?
|
| RNA Probes | 1 | 1992 | 111 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1745 | 0.030 |
Why?
|
| Doxycycline | 1 | 1975 | 344 | 0.030 |
Why?
|
| Acetic Acid | 1 | 1992 | 60 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2178 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1888 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 1992 | 149 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2014 | 260 | 0.020 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1992 | 96 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2012 | 99 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 520 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1992 | 351 | 0.020 |
Why?
|
| DNA Probes | 1 | 1992 | 541 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 58919 | 0.020 |
Why?
|
| Listeriosis | 1 | 2012 | 148 | 0.020 |
Why?
|
| Exocytosis | 1 | 1993 | 320 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2024 | 0.020 |
Why?
|
| Ileum | 1 | 1994 | 557 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 17878 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2007 | 5034 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2004 | 575 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6188 | 0.020 |
Why?
|
| Filgrastim | 1 | 2010 | 132 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1996 | 951 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 247 | 0.020 |
Why?
|
| Herpesvirus 2, Human | 1 | 2012 | 191 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1992 | 555 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2012 | 389 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1994 | 539 | 0.020 |
Why?
|
| Term Birth | 1 | 2011 | 138 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1992 | 586 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1998 | 8165 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1993 | 573 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2011 | 361 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1991 | 2467 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 927 | 0.020 |
Why?
|
| Granulocytes | 1 | 1992 | 551 | 0.020 |
Why?
|
| Incidence | 5 | 2012 | 21339 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1989 | 49 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2010 | 169 | 0.020 |
Why?
|
| Micropore Filters | 1 | 1989 | 22 | 0.020 |
Why?
|
| Immunity, Active | 1 | 1989 | 58 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2011 | 299 | 0.020 |
Why?
|
| Algorithms | 3 | 2012 | 14024 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2011 | 236 | 0.020 |
Why?
|
| Blood Component Removal | 1 | 2010 | 132 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.020 |
Why?
|
| Eczema | 1 | 2012 | 246 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 1759 | 0.020 |
Why?
|
| Child Development | 2 | 2012 | 2300 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 6520 | 0.020 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 263 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 2011 | 552 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2012 | 978 | 0.020 |
Why?
|
| Borrelia | 1 | 1989 | 66 | 0.020 |
Why?
|
| Fatty Acids | 5 | 1984 | 1808 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2009 | 221 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2009 | 92 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 3 | 2000 | 730 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2009 | 98 | 0.020 |
Why?
|
| Peptides | 2 | 2000 | 4354 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 7390 | 0.020 |
Why?
|
| Cephalometry | 1 | 2010 | 382 | 0.020 |
Why?
|
| Environmental Microbiology | 1 | 2008 | 47 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 1989 | 159 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 127 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 2008 | 71 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2015 | 1088 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2003 | 5074 | 0.020 |
Why?
|
| Massachusetts | 3 | 2003 | 8835 | 0.020 |
Why?
|
| Ampicillin | 2 | 1978 | 136 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 1440 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1996 | 1995 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14388 | 0.020 |
Why?
|
| Gossypium | 1 | 1987 | 36 | 0.020 |
Why?
|
| Axons | 2 | 1993 | 1671 | 0.020 |
Why?
|
| Textiles | 1 | 1987 | 45 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 1503 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 629 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 469 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1988 | 0.020 |
Why?
|
| Eosinophils | 1 | 1993 | 953 | 0.020 |
Why?
|
| Cell Wall | 4 | 1978 | 420 | 0.020 |
Why?
|
| Chorion | 1 | 2008 | 114 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1993 | 704 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2008 | 180 | 0.020 |
Why?
|
| Quercetin | 1 | 2007 | 97 | 0.020 |
Why?
|
| Disinfectants | 1 | 2008 | 129 | 0.020 |
Why?
|
| Diarrhea | 3 | 1997 | 1317 | 0.020 |
Why?
|
| Molecular Weight | 3 | 2000 | 2185 | 0.020 |
Why?
|
| Ions | 2 | 2000 | 256 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2007 | 363 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 1700 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2015 | 1546 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2000 | 3074 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 7050 | 0.020 |
Why?
|
| Endotoxins | 3 | 1995 | 520 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2012 | 739 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2008 | 177 | 0.020 |
Why?
|
| Aged | 6 | 2013 | 169092 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 1409 | 0.020 |
Why?
|
| Genotype | 2 | 2015 | 12977 | 0.020 |
Why?
|
| Dinitrochlorobenzene | 1 | 1985 | 18 | 0.020 |
Why?
|
| Disinfection | 1 | 2008 | 207 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 4140 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 2008 | 285 | 0.020 |
Why?
|
| Enterocytes | 1 | 2007 | 220 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3088 | 0.020 |
Why?
|
| Coagulase | 1 | 1985 | 54 | 0.020 |
Why?
|
| Natural Killer T-Cells | 1 | 2009 | 322 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 905 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9417 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 1008 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2010 | 728 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1991 | 1738 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2008 | 1788 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2010 | 751 | 0.020 |
Why?
|
| Mannitol | 1 | 1985 | 177 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2008 | 376 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2008 | 552 | 0.020 |
Why?
|
| Cell Membrane | 4 | 1982 | 3680 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2009 | 1084 | 0.010 |
Why?
|
| Lincosamides | 1 | 2004 | 4 | 0.010 |
Why?
|
| Antigens, Surface | 2 | 1979 | 1606 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6223 | 0.010 |
Why?
|
| Enteritis | 1 | 1985 | 162 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2509 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1985 | 211 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 1302 | 0.010 |
Why?
|
| Hexuronic Acids | 1 | 1984 | 145 | 0.010 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1985 | 239 | 0.010 |
Why?
|
| Sulfapyridine | 1 | 1983 | 5 | 0.010 |
Why?
|
| Aminosalicylic Acid | 1 | 1983 | 20 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1202 | 0.010 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1983 | 14 | 0.010 |
Why?
|
| Biotransformation | 1 | 1983 | 166 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 522 | 0.010 |
Why?
|
| Age Factors | 3 | 1994 | 18381 | 0.010 |
Why?
|
| Breath Tests | 1 | 2005 | 299 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15829 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2008 | 869 | 0.010 |
Why?
|
| Pregnancy Trimesters | 1 | 2004 | 197 | 0.010 |
Why?
|
| Intestine, Large | 2 | 1981 | 69 | 0.010 |
Why?
|
| Skin Window Technique | 1 | 2003 | 22 | 0.010 |
Why?
|
| Sulfasalazine | 1 | 1983 | 84 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 278 | 0.010 |
Why?
|
| Streptomycin | 2 | 1981 | 69 | 0.010 |
Why?
|
| Mannose-Binding Lectin | 1 | 2004 | 145 | 0.010 |
Why?
|
| Crohn Disease | 2 | 1993 | 2279 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2010 | 1067 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2010 | 939 | 0.010 |
Why?
|
| Macrolides | 1 | 2004 | 204 | 0.010 |
Why?
|
| Immunoelectrophoresis | 2 | 1993 | 94 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4269 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2012 | 2410 | 0.010 |
Why?
|
| Smoking | 2 | 2010 | 9054 | 0.010 |
Why?
|
| Lincomycin | 2 | 1979 | 5 | 0.010 |
Why?
|
| Staphylococcus epidermidis | 1 | 2003 | 123 | 0.010 |
Why?
|
| Neutrophils | 2 | 1990 | 3763 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2012 | 1740 | 0.010 |
Why?
|
| New York City | 1 | 2004 | 731 | 0.010 |
Why?
|
| Lymphokines | 1 | 1985 | 925 | 0.010 |
Why?
|
| Intestinal Perforation | 2 | 1981 | 249 | 0.010 |
Why?
|
| Hospitals | 1 | 2015 | 3879 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1990 | 2604 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 968 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1349 | 0.010 |
Why?
|
| Sterilization | 1 | 1982 | 132 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1981 | 317 | 0.010 |
Why?
|
| Homeostasis | 1 | 2012 | 3321 | 0.010 |
Why?
|
| Pharynx | 1 | 2004 | 432 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7236 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 6030 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1985 | 1390 | 0.010 |
Why?
|
| Infection Control | 1 | 2008 | 982 | 0.010 |
Why?
|
| Biopsy | 4 | 1994 | 6763 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64572 | 0.010 |
Why?
|
| Parents | 1 | 2014 | 3563 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1146 | 0.010 |
Why?
|
| Dental Pulp Diseases | 1 | 1980 | 12 | 0.010 |
Why?
|
| Dental Pulp Cavity | 1 | 1980 | 35 | 0.010 |
Why?
|
| Buffers | 1 | 2000 | 146 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1980 | 455 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 2278 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2003 | 339 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2006 | 3601 | 0.010 |
Why?
|
| Spores, Bacterial | 1 | 1980 | 113 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 9586 | 0.010 |
Why?
|
| Sprue, Tropical | 1 | 1979 | 6 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 359 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2005 | 589 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 1981 | 201 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1979 | 67 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2722 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 3392 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 605 | 0.010 |
Why?
|
| Rifampin | 1 | 1981 | 339 | 0.010 |
Why?
|
| Succinates | 2 | 1976 | 81 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 20077 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1978 | 25 | 0.010 |
Why?
|
| Adenine | 1 | 2004 | 985 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2007 | 12759 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 240 | 0.010 |
Why?
|
| Toxins, Biological | 1 | 1978 | 60 | 0.010 |
Why?
|
| Sulfamethoxazole | 1 | 1978 | 51 | 0.010 |
Why?
|
| Klebsiella | 1 | 1978 | 49 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 1810 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2000 | 1157 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1997 | 114 | 0.010 |
Why?
|
| Trimethoprim | 1 | 1978 | 78 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3419 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 1408 | 0.010 |
Why?
|
| Leukorrhea | 1 | 1977 | 4 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1981 | 598 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3303 | 0.010 |
Why?
|
| Fatty Acids, Volatile | 2 | 1976 | 103 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1978 | 340 | 0.010 |
Why?
|
| United States | 4 | 2008 | 72292 | 0.010 |
Why?
|
| Solubility | 1 | 1999 | 1089 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3461 | 0.010 |
Why?
|
| Hospitalization | 2 | 2013 | 10708 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 1057 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1981 | 1349 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1978 | 641 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 818 | 0.010 |
Why?
|
| Immunochemistry | 2 | 1991 | 116 | 0.010 |
Why?
|
| Sex Factors | 3 | 1994 | 10549 | 0.010 |
Why?
|
| Penicillins | 1 | 1979 | 402 | 0.010 |
Why?
|
| Absorption | 1 | 1996 | 242 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 1997 | 190 | 0.010 |
Why?
|
| Computer Systems | 1 | 1997 | 469 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1692 | 0.010 |
Why?
|
| Cephalosporins | 1 | 1977 | 198 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1999 | 813 | 0.010 |
Why?
|
| Methods | 1 | 1976 | 1065 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2378 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1981 | 1594 | 0.010 |
Why?
|
| Peritonsillar Abscess | 1 | 1974 | 18 | 0.010 |
Why?
|
| Peptococcus | 3 | 1978 | 5 | 0.010 |
Why?
|
| Nitrogen | 1 | 1996 | 345 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1994 | 145 | 0.010 |
Why?
|
| Leucine | 1 | 1996 | 548 | 0.010 |
Why?
|
| Enterococcus faecalis | 1 | 1976 | 245 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1998 | 1128 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5671 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 1997 | 406 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 1997 | 601 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13495 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1993 | 108 | 0.010 |
Why?
|
| Eubacterium | 3 | 1978 | 23 | 0.010 |
Why?
|
| Antigens, Ly | 2 | 1986 | 294 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 6861 | 0.010 |
Why?
|
| Ileostomy | 1 | 1994 | 121 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2191 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 3820 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1997 | 1155 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2533 | 0.010 |
Why?
|
| Temperature | 1 | 1979 | 2224 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1996 | 673 | 0.010 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1995 | 352 | 0.010 |
Why?
|
| Shigella | 1 | 1972 | 68 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1993 | 198 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2000 | 15250 | 0.010 |
Why?
|
| Glucose | 4 | 1978 | 4345 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1980 | 1094 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1265 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1994 | 15609 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1985 | 3077 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29601 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 297 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1993 | 219 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 1994 | 658 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 4937 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2003 | 5493 | 0.010 |
Why?
|
| Data Collection | 1 | 2000 | 3316 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 5838 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1994 | 1575 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1976 | 2231 | 0.010 |
Why?
|
| Basophils | 1 | 1992 | 407 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1992 | 314 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 8473 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 4472 | 0.010 |
Why?
|
| ROC Curve | 1 | 1997 | 3575 | 0.000 |
Why?
|
| Necrosis | 1 | 1993 | 1610 | 0.000 |
Why?
|
| Retrospective Studies | 3 | 2005 | 80583 | 0.000 |
Why?
|
| Chromatography, Gas | 2 | 1980 | 151 | 0.000 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 1932 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1994 | 3410 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20556 | 0.000 |
Why?
|
| Mice, Nude | 2 | 1986 | 3606 | 0.000 |
Why?
|
| Phenotype | 3 | 1986 | 16572 | 0.000 |
Why?
|
| Epitopes | 2 | 1985 | 2501 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1992 | 2669 | 0.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1999 | 4365 | 0.000 |
Why?
|
| Barium Sulfate | 2 | 1978 | 180 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 3882 | 0.000 |
Why?
|
| Weight Gain | 1 | 1996 | 2349 | 0.000 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1985 | 68 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 2 | 1993 | 9171 | 0.000 |
Why?
|
| Precancerous Conditions | 1 | 1992 | 982 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4770 | 0.000 |
Why?
|
| Immunoassay | 1 | 1988 | 744 | 0.000 |
Why?
|
| Drug Stability | 1 | 1985 | 291 | 0.000 |
Why?
|
| Uronic Acids | 1 | 1984 | 16 | 0.000 |
Why?
|
| Hexoses | 1 | 1984 | 29 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1985 | 645 | 0.000 |
Why?
|
| Amino Sugars | 1 | 1984 | 39 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12966 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1982 | 357 | 0.000 |
Why?
|
| Chemical Fractionation | 1 | 1980 | 60 | 0.000 |
Why?
|
| Elapid Venoms | 1 | 1980 | 40 | 0.000 |
Why?
|
| Survival Rate | 1 | 1995 | 12719 | 0.000 |
Why?
|
| Complement C5 | 1 | 1980 | 103 | 0.000 |
Why?
|
| Liver | 1 | 1996 | 7512 | 0.000 |
Why?
|
| Precipitins | 1 | 1979 | 4 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15498 | 0.000 |
Why?
|
| Freund's Adjuvant | 1 | 1979 | 145 | 0.000 |
Why?
|
| Internship and Residency | 1 | 2000 | 5878 | 0.000 |
Why?
|
| Membranes | 1 | 1979 | 165 | 0.000 |
Why?
|
| Serum Albumin, Bovine | 1 | 1979 | 321 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1980 | 671 | 0.000 |
Why?
|
| Tooth | 1 | 1980 | 210 | 0.000 |
Why?
|
| Peptococcaceae | 1 | 1977 | 1 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1977 | 175 | 0.000 |
Why?
|
| Glucosamine | 1 | 1978 | 128 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1977 | 212 | 0.000 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1980 | 661 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1980 | 734 | 0.000 |
Why?
|
| Galactose | 1 | 1978 | 294 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1980 | 773 | 0.000 |
Why?
|
| Drug Therapy, Combination | 2 | 1977 | 6305 | 0.000 |
Why?
|
| Skin Tests | 1 | 1978 | 637 | 0.000 |
Why?
|
| Valerates | 1 | 1975 | 20 | 0.000 |
Why?
|
| Proteus | 1 | 1974 | 11 | 0.000 |
Why?
|
| Micrococcus | 1 | 1974 | 13 | 0.000 |
Why?
|
| Contraceptives, Oral | 1 | 1977 | 553 | 0.000 |
Why?
|
| Propionates | 1 | 1975 | 183 | 0.000 |
Why?
|
| Lactates | 1 | 1975 | 404 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 6345 | 0.000 |
Why?
|
| Cattle | 1 | 1979 | 3841 | 0.000 |
Why?
|
| Aging | 1 | 1992 | 8700 | 0.000 |
Why?
|
| Granuloma | 1 | 1974 | 327 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 458 | 0.000 |
Why?
|
| Digestive System | 1 | 1972 | 244 | 0.000 |
Why?
|
| Shigella flexneri | 1 | 1972 | 119 | 0.000 |
Why?
|
| Meat | 1 | 1974 | 584 | 0.000 |
Why?
|
| Glutamates | 1 | 1972 | 389 | 0.000 |
Why?
|
| Tonsillectomy | 1 | 1974 | 278 | 0.000 |
Why?
|
| Cell Count | 1 | 1975 | 1834 | 0.000 |
Why?
|
| Binding Sites | 1 | 1977 | 6051 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1972 | 1519 | 0.000 |
Why?
|
| Lipids | 1 | 1978 | 3332 | 0.000 |
Why?
|